In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, Convergence of machine learning and genomics for precision oncology Nature Reviews Cancer RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn Is BPC 157 Legal? Understanding Its Status and Implications Compounded "semaglutide" is not FDA approved semaglutide.com